Independent investing research and personal finance for IrelandUnderstand. Decide. Compound.

Health3 min read

Tibolone in Ireland | Active metabolites and tissue-specific effects

Active metabolites and tissue-specific effects.

Archival photograph of a DXA scan in Bristol in 2011, illustrating the measurement of bone densityHealth / The Compound journal

Photo: Nick Smith photography · 2011 · CC BY-SA 3.0 · framed · Illustrative image.

At a glance

Tibolone is a systemic menopause treatment for selected people after menopause. Eligibility depends on personal history and the reason treatment is being considered. HSE guide

The Science Behind the Drug

Active metabolites and tissue-specific effects

After absorption, tibolone is converted to active metabolites. Some have oestrogenic activity, and another has progestogenic and androgenic activity. The overall effects vary across tissues. The metabolite profile helps explain why tibolone is reviewed as a distinct treatment with its own precautions. HPRA source

What the evidence measures

Discuss relief of the original symptoms and longer-term risks for the relevant age group and medical history. Results from one type of HRT should not simply be transferred to tibolone.

Bone outcomes and symptom relief need different measures. A DXA scan measures bone mineral density. A fracture is a clinical outcome. The Irish Livial leaflet describes the circumstances in which the product may be considered for preventing osteoporosis after menopause. HPRA Irish product information

Frame the treatment discussion

What to check Why it matters
Potential benefit what symptom or clinical concern should change?
Personal history what factors would affect the risk assessment?

Can I compare it with other HRT just by looking at the tablet strength?

The ingredient and active metabolites have distinct effects. Use comparisons from studies or guidelines for the relevant age and medical history rather than matching the numbers on two packs.

When to ask for help or a medication review

Mention unexplained bleeding and any history of stroke, blood clots or hormone-sensitive cancer. Get clinician advice on new or persistent bleeding. HSE patient guidance

Why a single tablet can have several hormonal effects

After it is absorbed, tibolone is converted into compounds with different hormonal activity. The balance can vary across tissues because each tissue has its own enzymes and receptors. That helps explain why findings from a trial of another HRT combination cannot be transferred to tibolone solely because the indications sound similar. Ask which evidence applies to your age, symptoms and medical history. Irish Livial product documents

Check what success looks like when the goal is bone protection

A bone density result and a fracture are different measures. The patient leaflet explains the particular circumstances in which tibolone may be considered for postmenopausal osteoporosis prevention. Ask whether this is part of the reason it was prescribed or whether the main aim is relief of menopause symptoms. The answer changes what would be reviewed and how long follow-up may take. Irish Livial product documents

Bring a record of new bleeding, dates of previous treatment changes and any history of stroke, blood clots or hormone-sensitive cancer. The HRT guide explains how product and route affect a menopause review. HSE tibolone guidance

Related guides

Hormone replacement therapy (HRT) · Continuous combined HRT · Sequential combined HRT · Oestrogen tablets, patches, gel and spray · Vaginal oestrogen · How to find the Irish patient leaflet

Archival photograph of a DXA scan in Bristol in 2011, illustrating the measurement of bone density. Image licence.

YOUR PRIVACY

Help us understand what gets read.

With your permission, anonymous Google Analytics measurements tell us which articles are useful. We do not send calculator entries or form values. You can decline and still read everything.